Squamous Cell Carcinoma, Serum
Also known as: SCC S
Use
This test is useful as a tumor marker for squamous cell carcinomas located in the head and neck, uterine cervix, lung, vulva, and esophagus. It is performed using the BRAHMS SCC Kryptor kit, and results from this kit should not be used interchangeably with results obtained by other methods. SCC Antigen levels alone are not necessarily indicative of the presence or absence of malignancy. In patients with known or suspected cancer, SCC levels should be considered alongside other diagnostic tests and procedures.
Special Instructions
Results obtained with different assay methods or kits cannot be used interchangeably. SCC Antigen levels alone should not be interpreted as evidence of the presence or absence of malignant disease. Elevated concentrations may also occur in benign conditions such as gynecological diseases, inflammatory lung disease, and liver or renal insufficiency.
Limitations
The test should not be solely relied upon for diagnosing cancer. Other diagnostic tests should be considered in conjunction with SCC Antigen level. Elevated SCC levels could be due to benign conditions and should be interpreted with caution.
New York Approved
Methodology
Immunoassay (Immunofluorescence)
Biomarkers
LOINC Codes
- 9679-2
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
0.5 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Allow specimen to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection.
Causes for Rejection
Specimens exposed to repeated freeze/thaw cycles.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 14 days |
| Frozen | 2 months |